Loading quote...
Cassava Sciences, Inc. (SAVA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Capital Market. The most recent ex-dividend date was December 13, 2012, with payment scheduled for December 24, 2012. market capitalization is approximately $94M.